Clopidogrel use as a risk factor for poor outcomes after kidney transplantation

Jennifer M. Williams, Janet E. Tuttle-Newhall, Mark Schnitzler, Nino Dzebisashvili, Huiling Xiao, David Axelrod, Harveshp Mogal, Krista L. Lentine

Research output: Contribution to journalArticlepeer-review

6 Scopus citations




Results: Clopidogrel fills within 90 days of transplant were associated with 61% of increased relative mortality risk and 23% of increased graft failure risk. Risks were higher in those whose last clopidogrel fill was more than 90 days before transplantation (111% for death, 59% for graft loss).

Conclusions: Clopidogrel use before kidney transplantation portends increased risks of post-transplant death and graft loss. Pharmacy claims may identify novel prognostic markers not currently captured in the transplant registry.

Original languageEnglish (US)
Pages (from-to)556-562
Number of pages7
JournalAmerican Journal of Surgery
Issue number4
StatePublished - Oct 1 2014


  • Clopidogrel Death Graft loss Kidney transplantation Outcomes Pharmacy records

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Clopidogrel use as a risk factor for poor outcomes after kidney transplantation'. Together they form a unique fingerprint.

Cite this